In order to help senior citizens better understanding how Medicare Part D works, you have been asked to convert Medicare Part D information into a flowchart. The attached ?Understanding the Medicare Part D Donut Hole? contains the most essential information but, because it was published in November of 2010 and then updated in 2014, the cost information needs to be updated for2016. The cost information includes: (1) deductible, (2) initial coverage limit, and (3) out-of-pocket (OOP) threshold.

The information on the chart is already updated for 2016.

Read the ?Understanding the Medicare Part D Donut Hole? carefully and thoroughly.

Use flowchart symbols correctly (6 points). There will be one point penalty for each incorrectly used symbol. No credit will be given if submitted flowchart contains 3 or more incorrect symbols.Present accurate and current information (3 points). The flowchart you submitted should display 2016 cost information. No credit will be given if you submitted a flowchart that contains outdated information.Concise (1 point). Concise is defined as no redundancy. If you see same sequence of activities repeat several times, you may need to analyze your implementation and see whether you should incorporate a loop into your flowchart.

Medicare Part D Medicare Part D TOTAL DRUG EXPENDITURE / ENROLLEE OUT OF POCKET COST PHASE1 YEARLY PREMIUM DEDUCTION PHASE 2 INITIAL COVERAGE PHASE 3 COVERAGE GAP (DONUT HOLE) PLAN PAYS PLAN PAYS 75 % OF THE COST (UP TO $2,213) BRAND NAME DRUGS THE PHASE HAS A CAP OF $3,310 AFTER WHICH MOVES TO PHASE 3 ENROLLEE YEARLY DEDUCTIBLE PLAN ( $0 - $360) ENROLLEE PAYS 25 % OF THE COST (UP TO $738) DRUG MANUFACTURER PAYS PHASE 4 CATASTROPHIC COVERAGE 5% OF THE BRAND NAME DRUGS 50% DISCOUNT WHICH IS COUNTED AS ENROLLEE OU T OF POCKET EXPENDITURE ENROLLEE PAYS 45% OF THE BRAND NAME DRUGS PLAN PAYS 42% OF THE GENERIC DRUGS ENROLLEE PAYS 58% OF THE GENERIC DRUGS GENERIC DRUGS Plan Pays 95% OF THE EXPENSE Enrollee Pays GREATER OF 5% OR $7.4 FOR BRANDED DRUGS AND $2.95 FOR GENERIC DRUGS ONCE MEMBERS OUT OF POCKET COST REACH $4,850 THEY MOVE TO PHASE 4 Medicare Part D TOTAL DRUG EXPENDITURE / ENROLLEE OUT OF POCKET COST PHASE1 YEARLY PREMIUM DEDUCTION PHASE 2 INITIAL COVERAGE PHASE 3 COVERAGE GAP (DONUT HOLE) PLAN PAYS PLAN PAYS 75 % OF THE COST (UP TO $2,213) BRAND NAME DRUGS THE PHASE HAS A CAP OF $3,310 AFTER WHICH MOVES TO PHASE 3 ENROLLEE YEARLY DEDUCTIBLE PLAN ( $0 - $360) ENROLLEE PAYS 25 % OF THE COST (UP TO $738) DRUG MANUFACTURER PAYS PHASE 4 CATASTROPHIC COVERAGE 5% OF THE BRAND NAME DRUGS 50% DISCOUNT WHICH IS COUNTED AS ENROLLEE OUT OF POCKET EXPENDITURE ENROLLEE PAYS 45% OF THE BRAND NAME DRUGS PLAN PAYS 42% OF THE GENERIC DRUGS ENROLLEE PAYS 58% OF THE GENERIC DRUGS GENERIC DRUGS Plan Pays 95% OF THE EXPENSE Enrollee Pays GREATER OF 5% OR $7.4 FOR BRANDED DRUGS AND $2.95 FOR GENERIC DRUGS ONCE MEMBERS OUT OF POCKET COST REACH $4,850 THEY MOVE TO PHASE 4